Implementierungsleitfaden Therapieziele Onkologie
1.0.0-ballot - Ballot Germany

Implementierungsleitfaden Therapieziele Onkologie - Local Development build (v1.0.0-ballot) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

: EnLiST-Setting-Achsen

Draft Stand: 2026-08-03

Raw xml | Download


<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="enlist-lot-setting"/>
  <language value="de"/>
  <text>
    <status value="generated"/>
    <div xml:lang="de" lang="de"><hr/><p><b>German</b></p><hr/><p class="res-header-id"><b>Generated Narrative: CodeSystem enlist-lot-setting</b></p><a name="enlist-lot-setting"> </a><a name="hcenlist-lot-setting"> </a><p>This case-sensitive code system <code>https://bih-cei.de/fhir/therapieziele-onkologie/CodeSystem/enlist-lot-setting</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap">eLoT<a name="enlist-lot-setting-eLoT"> </a></td><td>eLoT — frühes Setting</td><td>Early-stage Line of Therapy: resektable Situation — neoadjuvante, adjuvante und perioperative Systemtherapie.</td></tr><tr><td style="white-space:nowrap">aLoT<a name="enlist-lot-setting-aLoT"> </a></td><td>aLoT — fortgeschrittenes Setting</td><td>Advanced-stage Line of Therapy: lokal fortgeschrittene oder metastasierte Situation.</td></tr><tr><td style="white-space:nowrap">iLoT<a name="enlist-lot-setting-iLoT"> </a></td><td>iLoT — investigational</td><td>Investigational Line of Therapy: Systemtherapie mit ausschließlich nicht EMA/FDA-zugelassenen Komponenten, unabhängig vom Setting; eigene Zählachse.</td></tr></table></div>
  </text>
  <url
       value="https://bih-cei.de/fhir/therapieziele-onkologie/CodeSystem/enlist-lot-setting"/>
  <version value="1.0.0-ballot"/>
  <name value="EnlistLotSetting"/>
  <title value="EnLiST-Setting-Achsen"/>
  <status value="draft"/>
  <date value="2026-08-03T05:20:25+00:00"/>
  <publisher value="Berlin Institute of Health at Charité (BIH)"/>
  <contact>
    <name value="Berlin Institute of Health at Charité (BIH)"/>
    <telecom>
      <system value="url"/>
      <value value="https://www.bihealth.org"/>
    </telecom>
  </contact>
  <description
               value="Die drei getrennt gezählten Setting-Achsen der EnLiST-Notation: eLoT (early), aLoT (advanced), iLoT (investigational)."/>
  <jurisdiction>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="DE"/>
      <display value="Germany"/>
    </coding>
  </jurisdiction>
  <caseSensitive value="true"/>
  <content value="complete"/>
  <count value="3"/>
  <concept>
    <code value="eLoT"/>
    <display value="eLoT — frühes Setting"/>
    <definition
                value="Early-stage Line of Therapy: resektable Situation — neoadjuvante, adjuvante und perioperative Systemtherapie."/>
  </concept>
  <concept>
    <code value="aLoT"/>
    <display value="aLoT — fortgeschrittenes Setting"/>
    <definition
                value="Advanced-stage Line of Therapy: lokal fortgeschrittene oder metastasierte Situation."/>
  </concept>
  <concept>
    <code value="iLoT"/>
    <display value="iLoT — investigational"/>
    <definition
                value="Investigational Line of Therapy: Systemtherapie mit ausschließlich nicht EMA/FDA-zugelassenen Komponenten, unabhängig vom Setting; eigene Zählachse."/>
  </concept>
</CodeSystem>